EBS insider transactions
Emergent BioSolutions Inc. (EBS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for EBS
- Director Dayal Sujata Tyagi was granted 25,344 shares and sold $115,610 worth of shares (13,761 units at $8.40) as part of a pre-agreed trading plan, increasing direct ownership by 13% to 100,563 units (SEC Form 4) (withholding obligation)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Degolyer Donald W was granted 25,344 shares and sold $129,994 worth of shares (15,481 units at $8.40) as part of a pre-agreed trading plan, increasing direct ownership by 8% to 129,721 units (SEC Form 4) (withholding obligation)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Katkin Keith was granted 25,344 shares and sold $128,183 worth of shares (15,481 units at $8.28) as part of a pre-agreed trading plan, increasing direct ownership by 11% to 96,294 units (SEC Form 4) (withholding tax)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director White Marvin L was granted 25,344 shares, increasing direct ownership by 29% to 113,839 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Fowler John D Jr was granted 25,344 shares, increasing direct ownership by 506% to 30,350 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Richard Ronald was granted 25,344 shares, increasing direct ownership by 26% to 123,761 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Zoon Kathryn C sold $144,453 worth of shares (17,202 units at $8.40) as part of a pre-agreed trading plan and was granted 25,344 shares, increasing direct ownership by 11% to 79,941 units (SEC Form 4) to cover withholding tax4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Fowler Neal Franklin was granted 25,344 shares, increasing direct ownership by 19% to 160,847 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Chairman Harsanyi Zsolt was granted 25,344 shares, increasing direct ownership by 20% to 149,076 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Products Business Williams Paul Anthony was granted 100,111 shares, increasing direct ownership by 160% to 162,792 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, R&D, CMO Lowry Simon C was granted 100,111 shares, increasing direct ownership by 129% to 177,914 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Quality & Ethics, and CPL Glessner Coleen was granted 100,111 shares, increasing direct ownership by 96% to 204,219 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Chief Financial Officer Lindahl Richard S was granted 162,680 shares, increasing direct ownership by 76% to 378,047 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, General Counsel, Corp Sec Perl Jessica was granted 104,282 shares, increasing direct ownership by 171% to 165,286 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- President and CEO Papa Joseph C was granted 187,708 shares, increasing direct ownership by 61% to 493,153 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Bioservices Hartzel William was granted 100,111 shares, increasing direct ownership by 115% to 187,299 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SEC Form 4 filed by Williams Paul Anthony4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SEC Form 4 filed by EVP, Chief Financial Officer Lindahl Richard S4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- President and CEO Papa Joseph C covered exercise/tax liability with 37,055 shares, decreasing direct ownership by 11% to 305,445 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Fowler John D Jr was granted 5,006 shares (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- New insider Fowler John D Jr claimed no ownership of stock in the company (SEC Form 3)3 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, R&D, CMO Lowry Simon C covered exercise/tax liability with 10,636 shares, decreasing direct ownership by 12% to 77,803 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Bioservices Hartzel William covered exercise/tax liability with 9,493 shares, decreasing direct ownership by 10% to 87,188 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, General Counsel, Corp Sec Perl Jessica covered exercise/tax liability with 6,465 shares, decreasing direct ownership by 10% to 61,004 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Products Business Williams Paul Anthony covered exercise/tax liability with 9,397 shares, decreasing direct ownership by 12% to 66,681 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Chief Financial Officer Lindahl Richard S covered exercise/tax liability with 23,650 shares, decreasing direct ownership by 10% to 215,367 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Quality & Ethics, and CPL Glessner Coleen covered exercise/tax liability with 8,199 shares, decreasing direct ownership by 7% to 104,108 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Chief Financial Officer Lindahl Richard S covered exercise/tax liability with 683 shares, decreasing direct ownership by 0.28% to 239,017 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, General Counsel, Corp Sec Perl Jessica covered exercise/tax liability with 918 shares, decreasing direct ownership by 1% to 67,469 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Quality & Ethics, and CPL Glessner Coleen returned $315,009 worth of shares to the company (28,847 units at $10.92) and covered exercise/tax liability with 2,852 shares, decreasing direct ownership by 22% to 112,620 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Products Business Williams Paul Anthony returned $94,513 worth of shares to the company (8,655 units at $10.92) and covered exercise/tax liability with 1,022 shares, decreasing direct ownership by 11% to 76,194 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Bioservices Hartzel William returned $63,019 worth of shares to the company (5,771 units at $10.92) and covered exercise/tax liability with 630 shares, decreasing direct ownership by 6% to 96,681 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Chief Financial Officer Lindahl Richard S returned $504,013 worth of shares to the company (46,155 units at $10.92) and covered exercise/tax liability with 5,642 shares, decreasing direct ownership by 18% to 239,700 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, R&D, CMO Lowry Simon C covered exercise/tax liability with 3,543 shares, decreasing direct ownership by 4% to 88,439 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Richard Ronald sold $263,077 worth of shares (21,984 units at $11.97), exercised 25,748 shares at a strike of $5.02 and covered exercise/tax liability with 10,864 shares, decreasing direct ownership by 7% to 98,417 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Bioservices Hartzel William covered exercise/tax liability with 610 shares, decreasing direct ownership by 0.59% to 103,082 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Degolyer Donald W sold $187,623 worth of shares (17,801 units at $10.54), decreasing direct ownership by 13% to 119,858 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Dayal Sujata Tyagi sold $85,520 worth of shares (8,552 units at $10.00), decreasing direct ownership by 9% to 88,980 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Chief Financial Officer Lindahl Richard S covered exercise/tax liability with 4,995 shares, decreasing direct ownership by 2% to 291,497 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Quality & Ethics, and CPL Glessner Coleen sold $306,080 worth of shares (30,608 units at $10.00), decreasing direct ownership by 17% to 144,319 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Zoon Kathryn C sold $62,853 worth of shares (7,086 units at $8.87), decreasing direct ownership by 9% to 71,799 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Degolyer Donald W sold $67,831 worth of shares (7,844 units at $8.65), decreasing direct ownership by 5% to 137,659 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Bioservices Hartzel William covered exercise/tax liability with 4,263 shares, decreasing direct ownership by 4% to 103,692 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Quality & Ethics, and CPL Glessner Coleen covered exercise/tax liability with 1,249 shares, decreasing direct ownership by 0.71% to 174,927 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Bioservices Hartzel William covered exercise/tax liability with 1,167 shares, decreasing direct ownership by 1% to 107,955 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Products Business Williams Paul Anthony covered exercise/tax liability with 464 shares, decreasing direct ownership by 0.54% to 85,871 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Chief Financial Officer Lindahl Richard S covered exercise/tax liability with 2,733 shares, decreasing direct ownership by 0.91% to 296,492 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Katkin Keith sold $49,417 worth of shares (7,844 units at $6.30), decreasing direct ownership by 8% to 86,431 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- President and CEO Papa Joseph C bought $349,800 worth of shares (60,000 units at $5.83), increasing direct ownership by 21% to 342,500 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Richard Ronald was granted 34,403 shares, increasing direct ownership by 48% to 105,517 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director White Marvin L was granted 34,403 shares, increasing direct ownership by 64% to 88,495 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Fowler Neal Franklin was granted 34,403 shares, increasing direct ownership by 34% to 135,503 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Zoon Kathryn C was granted 34,403 shares, increasing direct ownership by 77% to 78,885 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Dayal Sujata Tyagi was granted 34,403 shares, increasing direct ownership by 54% to 97,532 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Katkin Keith was granted 34,403 shares, increasing direct ownership by 57% to 94,275 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Chairman Harsanyi Zsolt was granted 34,403 shares, increasing direct ownership by 39% to 123,732 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Degolyer Donald W was granted 34,403 shares, increasing direct ownership by 31% to 145,503 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- Director Sullivan Louis W was granted 34,403 shares, increasing direct ownership by 33% to 139,098 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- SVP, Bioservices Hartzel William covered exercise/tax liability with 561 shares, decreasing direct ownership by 0.51% to 109,122 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)
- EVP, Quality & Ethics, and CPL Glessner Coleen covered exercise/tax liability with 480 shares, decreasing direct ownership by 0.27% to 176,176 units (SEC Form 4)4 - Emergent BioSolutions Inc. (0001367644) (Issuer)